Literature DB >> 1711392

Phylogeny of tachykinin receptor localization in the vertebrate central nervous system: apparent absence of neurokinin-2 and neurokinin-3 binding sites in the human brain.

M M Dietl1, J M Palacios.   

Abstract

Binding of [125I]Bolton-Hunter labeled tachykinins substance P (BHSP), neurokinin A (BHNKA) and eledoisin (BHELE) to brain sections from several vertebrates was investigated by receptor autoradiography. Densities of BHSP binding sites were low in fish brain, increased in lower vertebrates, were high in birds and rodents, and relatively constant in cat, monkey and human. In contrast, BHELE binding site densities were moderate in fish brain and high in frog, snake, chick, pigeon, mouse and rat brain. Low and very low densities were localized in guinea pig and cat, while no significant BHELE specific binding was found in monkey and human brain. BHSP and BHELE binding sites were distinctly distributed in the vertebrate brains analyzed. Each ligand showed a characteristic regional distribution which was similar from species to species. The affinity profiles of tachykinins for BHSP and BHELE binding sites as analyzed on frog, chick and rat brain sections, corresponded to the NK1 and NK3 receptor types, respectively. No BHNKA binding sites could be detected in any vertebrate brain investigated. In conclusion, marked species variations exist in the density and distribution of tachykinin receptor types in the vertebrate brain. Thus, neurokinin A receptors (NK2 type) seem to be absent in the vertebrate central nervous system and, while substance P receptors (NK1 type) appear to be preserved and increase in density during evolution, the contrary seems to happen for the eledoisin receptors (NK3 type) which are more abundant in lower vertebrates and apparently absent in primate, particularly human brain.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1711392     DOI: 10.1016/0006-8993(91)91623-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  8 in total

Review 1.  Substance P receptor antagonists in psychiatry: rationale for development and therapeutic potential.

Authors:  Inga Herpfer; Klaus Lieb
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Functional characterization by heterologous expression of a novel cloned tachykinin peptide receptor.

Authors:  L F Donaldson; C A Haskell; M R Hanley
Journal:  Biochem J       Date:  1996-11-15       Impact factor: 3.857

3.  Distribution and pharmacological characterization of primate NK-1 and NK-3 tachykinin receptors in the central nervous system of the rhesus monkey.

Authors:  Masatoshi Nagano; Fumihito Saitow; Eisuke Haneda; Shiro Konishi; Motoharu Hayashi; Hidenori Suzuki
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

4.  Functional expression of a novel human neurokinin-3 receptor homolog that binds [3H]senktide and [125I-MePhe7]neurokinin B, and is responsive to tachykinin peptide agonists.

Authors:  J E Krause; P T Staveteig; J N Mentzer; S K Schmidt; J B Tucker; R M Brodbeck; J Y Bu; V V Karpitskiy
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-07       Impact factor: 11.205

5.  Use of selective antagonists to dissociate the central cardiovascular and behavioural effects of tachykinins on NK1 and NK2 receptors in the rat.

Authors:  C Tschöpe; P Picard; J Culman; A Prat; K Itoi; D Regoli; T Unger; R Couture
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

6.  Primary structure and receptor-binding properties of a neurokinin A-related peptide from frog gut.

Authors:  Y Wang; T Badgery-Parker; S Lovas; N Chartrel; H Vaudry; E Burcher; J M Conlon
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

7.  NK1 receptor blockade is ineffective in improving outcome following a balloon compression model of spinal cord injury.

Authors:  Anna Victoria Leonard; Emma Thornton; Robert Vink
Journal:  PLoS One       Date:  2014-05-23       Impact factor: 3.240

8.  Neurokinin-3 Receptor Binding in Guinea Pig, Monkey, and Human Brain: In Vitro and in Vivo Imaging Using the Novel Radioligand, [18F]Lu AF10628.

Authors:  Katarina Varnäs; Sjoerd J Finnema; Vladimir Stepanov; Akihiro Takano; Miklós Tóth; Marie Svedberg; Søren Møller Nielsen; Nikolay A Khanzhin; Karsten Juhl; Benny Bang-Andersen; Christer Halldin; Lars Farde
Journal:  Int J Neuropsychopharmacol       Date:  2016-08-12       Impact factor: 5.176

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.